Startup Profile: Lactiga (020)

Episode 20 September 05, 2021 00:48:50
Startup Profile: Lactiga (020)
Innovation4Alpha
Startup Profile: Lactiga (020)

Sep 05 2021 | 00:48:50

/

Show Notes

Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent mucosal infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. They are unlocking the full therapeutic value of human milk antibodies to create the next-generation of anti-infectives that can battle even the world’s most dangerous pathogens including Covid. Lactiga has earned multiple awards, media attention (Globe & Mail, CTV, Toronto Star) and is participating in the On Deck Health (ODH2) cohort.

AngelMD Profile: https://www.angelmd.co/en/startups/lactiga

Other Episodes

Episode 24

June 29, 2022 00:22:51
Episode Cover

Sage Medical: Bringing Intelligence to Medical Coding & Billing (224)

With Sage’s AI Driven Medical Coding, Billing and Dictation, practitioners are eliminating the costly overhead of a medical coder while increasing productivity by 20%....

Listen

Episode 13

May 18, 2022 00:27:35
Episode Cover

Getting Why Right: Colorado Medical Society (213)

Bryan Campbell leads the Colorado Medical Society and started of his mission going back to the fundamental question of why CMS exists. How can...

Listen

Episode 18

August 30, 2021 00:42:32
Episode Cover

Julie Anderson of Cambia Grove (018)

Julie Anderson is the Director of Strategic Initiatives at Cambia Grove and a healthcare veteran.Cambia Grove is a health care innovation hub focused on...

Listen